Methotrexate Ameliorates Systemic Inflammation and Septic Associated-Lung Damage in a Cecal Ligation and Puncture Septic Rat Model

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Sep 10

PMID 34502521

Citations 6

Authors

Josep Bringue

Raquel Guillamat-Prats

Maria Luisa Martinez

Eva Torrents

Marta Camprubi-Rimblas

Lluis Blanch

Antonio Artigas

Affiliations

Soon will be listed here.

Abstract

Background: Sepsis is a serious, heterogeneous clinical entity produced by a severe and systemic host inflammatory response to infection. Methotrexate (MTX) is a folate-antagonist that induces the generation of adenosine and also inhibits JAK/STAT pathway; MTX it is widely used as an anti-inflammatory drug to control the immune system.

Objective: The aim of this study was to assess the beneficial effects of a single and low dose of MTX in the systemic response and acute lung injury (ALI) induced by sepsis. As in the clinics, we treated our animals with antibiotics and fluids and performed the source control to mimic the current clinic treatment.

Methods And Main Results: Sepsis was induced in rats by a cecal ligation puncture (CLP) procedure. Six hours after induction of sepsis, we proceeded to the source control; fluids and antibiotics were administered at 6 h and 24 h after CLP. MTX (2.5 mg/Kg) was administered 6 h after the first surgery in one CLP experimental group and to one Sham group. A protective effect of MTX was observed through a significant reduction of pro-inflammatory cytokines and a decrease infiltration of inflammatory cells in the lung. In addition, we found a regulation in adenosine receptor A2aR and the metalloproteinases by MTX.

Conclusion: A single, low dose of MTX attenuates sepsis lung-associated damage by decreasing pro-inflammatory response, infiltration of pro-inflammatory cells and avoiding defective tissue lung remodeling.

Citing Articles

INDUCTION OF EARLY PULMONARY SENESCENCE IN EXPERIMENTAL SEPSIS.

Mosenlechner M, Schlosser D, Braumuller S, Dorfer L, Mannes M, Kawach R Shock. 2024; 63(3):448-455.

PMID: 39637172 PMC: 11882169. DOI: 10.1097/SHK.0000000000002512.

Protective Effects and Mechanisms of Luteolin against Acute Respiratory Distress Syndrome: Network Pharmacology and and Studies.

Li Q, Chen J, Ren Y, Yang Z, Wang M, Zhang W Curr Pharm Des. 2024; 30(18):1404-1418.

PMID: 38616753 DOI: 10.2174/0113816128289341240327072531.

Phospholipid transfer protein ameliorates sepsis-induced cardiac dysfunction through NLRP3 inflammasome inhibition.

Wang J, Hou J, Peng C Open Med (Wars). 2024; 19(1):20240915.

PMID: 38584827 PMC: 10996989. DOI: 10.1515/med-2024-0915.

Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS).

Huang Q, Le Y, Li S, Bian Y Respir Res. 2024; 25(1):30.

PMID: 38218783 PMC: 10788036. DOI: 10.1186/s12931-024-02678-5.

Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup.

Xu H, Sheng S, Luo W, Xu X, Zhang Z Front Immunol. 2023; 14:1277161.

PMID: 38035100 PMC: 10682474. DOI: 10.3389/fimmu.2023.1277161.

References

Monneret G, Venet F . A rapidly progressing lymphocyte exhaustion after severe sepsis. Crit Care. 2012; 16(4):140. PMC: 3580699. DOI: 10.1186/cc11416. View

Ferrer R, Martinez M, Goma G, Suarez D, Alvarez-Rocha L, de la Torre M . Improved empirical antibiotic treatment of sepsis after an educational intervention: the ABISS-Edusepsis study. Crit Care. 2018; 22(1):167. PMC: 6013897. DOI: 10.1186/s13054-018-2091-0. View

Nakazawa F, Matsuno H, Yudoh K, Katayama R, Sawai T, Uzuki M . Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J Rheumatol. 2001; 28(8):1800-8. View

Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29(4):530-8. DOI: 10.1007/s00134-003-1662-x. View

Martinez M, Ferrer R, Torrents E, Guillamat-Prats R, Goma G, Suarez D . Impact of Source Control in Patients With Severe Sepsis and Septic Shock. Crit Care Med. 2016; 45(1):11-19. DOI: 10.1097/CCM.0000000000002011. View

Friebe D, Yang T, Schmidt T, Borg N, Steckel B, Ding Z . Purinergic signaling on leukocytes infiltrating the LPS-injured lung. PLoS One. 2014; 9(4):e95382. PMC: 3991673. DOI: 10.1371/journal.pone.0095382. View

Mira J, Gentile L, Mathias B, Efron P, Brakenridge S, Mohr A . Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome. Crit Care Med. 2016; 45(2):253-262. PMC: 5243156. DOI: 10.1097/CCM.0000000000002074. View

Wollner A, Wollner S, Smith J . Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b/CD18) expression on FMLP-stimulated neutrophils. Am J Respir Cell Mol Biol. 1993; 9(2):179-85. DOI: 10.1165/ajrcmb/9.2.179. View

Sonego F, Alves-Filho J, Cunha F . Targeting neutrophils in sepsis. Expert Rev Clin Immunol. 2014; 10(8):1019-28. DOI: 10.1586/1744666X.2014.922876. View

10.

Downey J, Han J . Cellular activation mechanisms in septic shock. Front Biosci. 1998; 3:d468-76. DOI: 10.2741/a293. View

11.

Condor Capcha J, Moreira R, Rodrigues C, Silveira M, Andrade L, Gomes S . Using the Cecal Ligation and Puncture Model of Sepsis to Induce Rats to Multiple Organ Dysfunction. Bio Protoc. 2021; 11(7):e3979. PMC: 8054174. DOI: 10.21769/BioProtoc.3979. View

12.

Gordon J, Li F, Zhang X, Wang W, Zhao X, Nayyar A . The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals. J Leukoc Biol. 2005; 78(6):1265-72. DOI: 10.1189/jlb.0805458. View

13.

Naamani O, Chaimovitz C, Douvdevani A . Pharmacological preconditioning with adenosine A(1) receptor agonist suppresses cellular immune response by an A(2A) receptor dependent mechanism. Int Immunopharmacol. 2014; 20(1):205-12. DOI: 10.1016/j.intimp.2014.02.011. View

14.

Hotchkiss R, Monneret G, Payen D . Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013; 13(3):260-8. PMC: 3798159. DOI: 10.1016/S1473-3099(13)70001-X. View

15.

Rittirsch D, Hoesel L, Ward P . The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2006; 81(1):137-43. DOI: 10.1189/jlb.0806542. View

16.

Pelekanou A, Tsangaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A . Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care. 2009; 13(6):R172. PMC: 2811921. DOI: 10.1186/cc8148. View

17.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

18.

Ali R, Gandhi A, Meng H, Yalavarthi S, Vreede A, Estes S . Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commun. 2019; 10(1):1916. PMC: 6478874. DOI: 10.1038/s41467-019-09801-x. View

19.

Antonioli L, Fornai M, Blandizzi C, Pacher P, Hasko G . Adenosine signaling and the immune system: When a lot could be too much. Immunol Lett. 2018; 205:9-15. DOI: 10.1016/j.imlet.2018.04.006. View

20.

Gillitzer R, Goebeler M . Chemokines in cutaneous wound healing. J Leukoc Biol. 2001; 69(4):513-21. View